These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand. Reechaipichitkul W; Assawasanti K; Chaimanee P Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993 [TBL] [Abstract][Full Text] [Related]
11. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. van der Eerden MM; Vlaspolder F; de Graaff CS; Groot T; Bronsveld W; Jansen HM; Boersma WG Thorax; 2005 Aug; 60(8):672-8. PubMed ID: 16061709 [TBL] [Abstract][Full Text] [Related]
12. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Borch JE; Andersen KE; Bindslev-Jensen C Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):357-62. PubMed ID: 16623858 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis. Marras TK; Nopmaneejumruslers C; Chan CK Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Park HK; Song JU; Um SW; Koh WJ; Suh GY; Chung MP; Kim H; Kwon OJ; Jeon K Respir Med; 2010 Nov; 104(11):1729-35. PubMed ID: 20605087 [TBL] [Abstract][Full Text] [Related]
15. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Ioachimescu OC; Ioachimescu AG; Iannini PB Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482 [TBL] [Abstract][Full Text] [Related]
16. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Bratzler DW; Ma A; Nsa W Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289 [TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171 [TBL] [Abstract][Full Text] [Related]
18. Clinical features of community-acquired pneumonia treated at Srinagarind Hospital, Khon Kaen, Thailand. Reechaipichitkul W; Tantiwong P Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):355-61. PubMed ID: 12236437 [TBL] [Abstract][Full Text] [Related]
19. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876 [TBL] [Abstract][Full Text] [Related]
20. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Jasti H; Mortensen EM; Obrosky DS; Kapoor WN; Fine MJ Clin Infect Dis; 2008 Feb; 46(4):550-6. PubMed ID: 18194099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]